missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD264 (TRAIL-R4) Monoclonal Antibody (TRAIL-R4-01), FITC
Mouse Monoclonal Antibody
Marque: Invitrogen™ MA110163
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
This antibody reacts with an extracellular epitope of TRAIL-R4, a 42 kDa transmembrane protein expressed on various blood cells.
TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has signaling capacity similar to that of TRAIL-R1 and TRAIL-R2 with respect to NF-kappaB activation, but differs in its inability to induce apoptosis. Like TRAIL-R1 and TRAIL-R2, this receptor shows widespread tissue expression. The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.
Spécification
| CD264 (TRAIL-R4) | |
| Monoclonal | |
| 0.1 mg/mL | |
| PBS with 0.2% BSA and 15mM sodium azide; pH 7.4 | |
| Q9UBN6 | |
| TNFRSF10D | |
| TRAIL-R4 (aa 1-210) - hIgGhc fusion protein. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 |
| Flow Cytometry | |
| TRAIL-R4-01 | |
| FITC | |
| TNFRSF10D | |
| CD264; DCR2; Decoy receptor 2; TNF receptor superfamily member 10d; TNF receptor-related receptor for TRAIL; TNF-related apoptosis-inducing ligand receptor 4; TNFRSF10D; TRAIL receptor 4; TRAIL receptor with a truncated death domain; TRAILR4; TRAIL-R4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; tumor necrosis factor receptor superfamily member 10d, decoy with truncated death domain; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; UNQ251/PRO288 | |
| Mouse | |
| Size-exclusion chromatography | |
| RUO | |
| 8793 | |
| 4°C, store in dark, DO NOT FREEZE! | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu